Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Borden

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Pharmaceutical Research|March 6, 1998
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteersE C Borden
Clinical Immunology and Immunopathology|January 1, 1992
Interferons: pleiotropic cellular modulatorsE C Borden
The Johns Hopkins Medical Journal|February 1, 1974
Viruses and breast cancer: implications of mouse and human studiesE C Borden
Journal of the National Cancer Institute|April 6, 1988
Augmented tumor-associated antigen expression by interferonsE C Borden
Pharmacology & Therapeutics|January 1, 1988
Effects of interferons in neoplastic diseases of manE C Borden
Journal of the National Cancer Institute|June 1, 1978
Synergistic cytotoxicity for L929 cells of polyriboinosinic-polyribocytidylic acid and amphotericin B methyl esterE C Borden
The New England Journal of Medicine|May 28, 1992
Interferons--expanding therapeutic rolesE C Borden
Seminars in Oncology|December 29, 2000
Melanoma and pregnancyE C Borden
Progress in Clinical and Biological Research|January 1, 1983
Interferons: in pursuit of the promiseE C Borden
Cancer|December 1, 1984
Progress toward therapeutic application of interferons, 1979-1983E C Borden
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Pharmaceutical Research|March 6, 1998
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteersE C Borden
Clinical Immunology and Immunopathology|January 1, 1992
Interferons: pleiotropic cellular modulatorsE C Borden
The Johns Hopkins Medical Journal|February 1, 1974
Viruses and breast cancer: implications of mouse and human studiesE C Borden
Journal of the National Cancer Institute|April 6, 1988
Augmented tumor-associated antigen expression by interferonsE C Borden
Pharmacology & Therapeutics|January 1, 1988
Effects of interferons in neoplastic diseases of manE C Borden
Journal of the National Cancer Institute|June 1, 1978
Synergistic cytotoxicity for L929 cells of polyriboinosinic-polyribocytidylic acid and amphotericin B methyl esterE C Borden
The New England Journal of Medicine|May 28, 1992
Interferons--expanding therapeutic rolesE C Borden
Seminars in Oncology|December 29, 2000
Melanoma and pregnancyE C Borden
Progress in Clinical and Biological Research|January 1, 1983
Interferons: in pursuit of the promiseE C Borden
Cancer|December 1, 1984
Progress toward therapeutic application of interferons, 1979-1983E C Borden
Pageof 22